Compare PGC & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PGC | QTRX |
|---|---|---|
| Founded | 1921 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 453.9M | 352.7M |
| IPO Year | N/A | 2017 |
| Metric | PGC | QTRX |
|---|---|---|
| Price | $28.02 | $6.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $35.33 | $11.33 |
| AVG Volume (30 Days) | 104.5K | ★ 623.8K |
| Earning Date | 01-27-2026 | 11-10-2025 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | ★ 6.12 | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $248,809,000.00 | $130,203,000.00 |
| Revenue This Year | $27.34 | N/A |
| Revenue Next Year | $16.59 | $28.28 |
| P/E Ratio | $14.64 | ★ N/A |
| Revenue Growth | ★ 18.63 | N/A |
| 52 Week Low | $23.96 | $4.05 |
| 52 Week High | $35.41 | $12.41 |
| Indicator | PGC | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 41.26 |
| Support Level | $29.41 | $6.23 |
| Resistance Level | $30.39 | $7.10 |
| Average True Range (ATR) | 0.59 | 0.32 |
| MACD | -0.23 | -0.16 |
| Stochastic Oscillator | 0.40 | 8.54 |
Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.